When looking at monocyte subsets, a Chinese case–control study of 100 patients treated with PCI for de novo STEMI, showed that intermediate monocytes (CD14++CD16+, 2.26-fold increase) and intermediate monocyte-platelet aggregates (MPA, 2.69-fold increase) were elevated during the first 7 days post-STEMI compared to stable CHD controls, with a peak at day two [31]. This evidence concerns the gene CD14 and coronary artery disorder.